RxDoctor Payments Data

Akash Anand, MD

Plastic Surgery within the Head & Neck · Metairie, LANPI 1720262108

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Aerin Medical Inc. accounts for 71.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $243 and has fallen 91.5% since, to $21 in 2025.

$339in general payments, 2019–2025

Across 7 payments — averaging $48.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$243
  • Sanofi$22
  • Paratek Pharmaceuticals, Inc.$21
  • Regeneron Healthcare Solutions, Inc.$20
  • Inspire Medical Systems, Inc.$18
  • Medtronic$17

What the payments were for

  • Food & beverage$339100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$390,518
Medicare patients
212
Services billed
771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone503$3,773
Azelastine Hcl57$1,777
Fluticasone Propionate132$1,759
Azithromycin366$1,357
Ibuprofen175$675
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort12$608
Ipratropium Bromide23$558
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav49$494
Doxycycline Hyclate28$225
Montelukast Sodium21$87
Mupirocin11$69
Prednisone21$46
Amoxicillin12$15

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →